Outcome of Elderly Patients With Appendicitis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04791657 |
|
Recruitment Status :
Completed
First Posted : March 10, 2021
Last Update Posted : March 10, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Appendicitis Acute | Procedure: Appendectomy |
| Study Type : | Observational |
| Actual Enrollment : | 80 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | Factors Associated With Postoperative Complications After the Surgical Treatment of Appendicitis in Elderly Patients |
| Actual Study Start Date : | January 1, 2017 |
| Actual Primary Completion Date : | December 31, 2020 |
| Actual Study Completion Date : | December 31, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients without complications
Patients with uneventful recovery
|
Procedure: Appendectomy
Surgical treatment for appendicitis |
|
Patients with complications
Patients experiencing complications within 30 days postoperatively
|
Procedure: Appendectomy
Surgical treatment for appendicitis |
- 30-day postoperative complication rate [ Time Frame: 30 days ]The primary clinical outcome of interest is 30-day postoperative complications. The Clavien-Dindo classification will be used to grade postoperative outcomes and complications
- In-hospital mortality rate [ Time Frame: 30 days ]In-hospital mortality is defined as death occurring during the hospital stay after the surgical procedure
- 30-day readmission rate [ Time Frame: 30 days ]30-day readmission is defined as unplanned readmission to the hospital within 30 days of discharge.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years and older (Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients aged 65 years and older
- Patients undergoing appendectomy for acute appendicitis (pathologically confirmed)
- Patients having complete records of clinical data and postoperative follow-up records
Exclusion Criteria:
- Patients younger than 65 years
- Patients undergoing an appendectomy as part of another major operation or those with appendiceal malignancy
- Patients who are treated nonoperatively for acute appendicitis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04791657
| Turkey | |
| Gulhane Training and Research Hospital | |
| Ankara, Turkey, 06010 | |
| Principal Investigator: | Suleyman U Celik, MD | Gulhane Training and Research Hospital |
| Responsible Party: | Suleyman Utku Celik, Principal Investigator, Gulhane Training and Research Hospital |
| ClinicalTrials.gov Identifier: | NCT04791657 |
| Other Study ID Numbers: |
Gulhane2021-51 |
| First Posted: | March 10, 2021 Key Record Dates |
| Last Update Posted: | March 10, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | There is no plan to share IPD |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
appendicitis geriatrics |
|
Appendicitis Intraabdominal Infections Infections Gastroenteritis |
Gastrointestinal Diseases Digestive System Diseases Cecal Diseases Intestinal Diseases |

